Traditional Chinese medicine for treating bronchial asthma

Abstract

The invention discloses a traditional Chinese medicine for treating bronchial asthma, which is prepared by dispensing a component one with any five to six medicines in a component two, wherein the component one contains 6-10 parts of rhodiola root, 6-10 parts of ligustrum lucidum, 6-10 parts of gynostemma pentaphylla, 6-8 parts of tag, 4-8parts of cinnamon,6-8 parts of radix sophorae falvescentis,6-10 parts of baikal skullcap root, 6-10 parts of earthworm, 6-8 parts of almond, 6-10 parts of brassica alba boiss, 2-8 parts of agilawood,6-12 parts of radix paeoniae alba, 4-8 parts of asarum, 4-8parts of fructus gleditsiae and 2-8 parts of datura flower; the component two contains 6-10 parts of ginseng, 6-10 parts of rhizoma atractylodis, 6-10 parts of PORIA from Yunnan of China, 6-10 partsof root of fangji, 6-8 parts of lepidium seed, 6-10 parts of magnolia officinalis, 6-8 parts of costus root, 6-8 parts of rhizoma zingiberis, 6-8 parts of rhizoma coptidis, 6-10 parts of shizandra berry, 6-10 parts of peucedanum root, 6-10 parts of perilla-seed, 6-10 parts of radish seed, 6-8 parts of liquorice and 6-8 parts of ant. With no toxic and side effect and obvious curative effect, the invention can treat various symptoms, abnormal pathology, physiological change or basic aetiological agent of asthma, fully replace cortical hormone, alleviate the pain of patients, clear away corticalhormone digested by human bodies for a long time and toxin deposited by chemical medicaments, and adjust the internal secretion of the human bodies.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for treating bronchial asthma. Background technique [0002] Asthma is one of the most common chronic diseases in the world today. It is caused by a variety of viruses or bacteria. It is a difficult and miscellaneous disease. A chronic respiratory disease that seriously endangers people's health. Especially in the past 20 years, due to the abuse of corticosteroids, the morbidity and mortality of asthma have continued to increase, and it is still increasing at a rate of 20% to 50% per decade. Asthma has become the second most common disease in the world after cancer. Major deadly and disabling diseases. [0003] Bronchial asthma is a chronic airway inflammation involving various cells. This inflammation makes the susceptible person have airway hyperresponsiveness to various stimulating factors, and can cause airway narrowing, manifested as recurrent asthma, respiratory Symptoms such as dyspnea, ...

AI Technical Summary

Problems solved by technology

Western medicine relies on corticosteroids, and aminophylline is the first choice for treatment, but the side effects of long-term systemic use of corticosteroids have been perceived by everyone, and corticosteroids only relieve asthma symptoms, and do not fundamentally solve the cause of asthma.